Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells. 1998

S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
Department of Clinical Bio-regulatory Science, Kyoto University Graduate School of Medicine, Japan.

Lysophosphatidylcholine (lyso-PC) accumulates in tissues undergoing inflammation and atherosclerosis, where an infiltration of T cells is also seen. We found that lyso-PC increased IFN-gamma production and CD40L expression in CD4+ T cells stimulated with anti-CD3 Ab and recombinant CD80 molecules, whereas lyso-PC did not affect IL-2 and IL-4 production. These results suggest that lyso-PC, in combination with other stimuli, may regulate CD4+ T cell functions to propagate local inflammatory reactions and also imply a novel role played by a modified lipid in the selection of Th1/Th2 immune response as well as in the T cell mediated pathogenesis in atherosclerosis.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008244 Lysophosphatidylcholines Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties. Lysolecithin,Lysolecithins,Lysophosphatidylcholine
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
March 1996, European journal of immunology,
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
September 1999, Journal of immunology (Baltimore, Md. : 1950),
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
January 1995, The Journal of clinical investigation,
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
August 2000, Journal of autoimmunity,
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
July 2004, Journal of leukocyte biology,
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
December 2012, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
February 1994, Journal of immunology (Baltimore, Md. : 1950),
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
November 1997, Cellular immunology,
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
May 2001, Current protocols in cytometry,
S Sakata-Kaneko, and Y Wakatsuki, and T Usui, and Y Matsunaga, and T Itoh, and E Nishi, and N Kume, and T Kita
March 2002, The Journal of experimental medicine,
Copied contents to your clipboard!